950 — Lee's Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00- HK$624.17m
- HK$330.52m
- HK$1.44bn
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals
Brief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA
Brief: Lee's Pharmaceutical Receives FDA Approval Of Supplemental New Drug Application For Adasuve
Brief: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform And Assets, Driving Pipeline Expansion And Advancing Global Partnership With UCB Through Acquired Rights
Brief: Lee's Pharmaceutical Says Unit Buys Assets For US$15 Million
Brief: Lee's Pharmaceutical Says Socazolimab Approved For Marketing By NMPA
Brief: Lee's Pharmaceutical Sees Profit Between HK$83 Million To HK$106 Million For Year
Brief: Lee's Pharmaceutical Says Unit Entered Compensation Agreement For State-Owned Land
Brief: Lee's Pharmaceutical Says NMPA Accepted Application For Clinical Trial Of Recombinant Anfibatide Injection
Brief: Lee's Pharmaceutical Says Drug Registration Certificate For Adasuve Obtained From China NMPA
Brief: Lee's Pharmaceutical Announces Disposal Of Assets
Brief: Lee's Pharmaceutical Sees Unaudited Net Profit Attributable Between Hk$12 Mln & Hk$17 Mln For Six Months